MY104345A - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- MY104345A MY104345A MYPI88001240A MYPI19881240A MY104345A MY 104345 A MY104345 A MY 104345A MY PI88001240 A MYPI88001240 A MY PI88001240A MY PI19881240 A MYPI19881240 A MY PI19881240A MY 104345 A MY104345 A MY 104345A
- Authority
- MY
- Malaysia
- Prior art keywords
- glycyrrhizinate
- calcitonin
- pharmaceutical compositions
- present
- absorption
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 4
- 102000055006 Calcitonin Human genes 0.000 abstract 3
- 108060001064 Calcitonin Proteins 0.000 abstract 3
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 abstract 3
- 229960004015 calcitonin Drugs 0.000 abstract 3
- 229940074774 glycyrrhizinate Drugs 0.000 abstract 3
- 238000010521 absorption reaction Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT22647/87A IT1223132B (it) | 1987-11-13 | 1987-11-13 | Composizione farmaceutica per somministrazione nasale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY104345A true MY104345A (en) | 1994-03-31 |
Family
ID=11198823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI88001240A MY104345A (en) | 1987-11-13 | 1988-10-31 | Pharmaceutical compositions |
Country Status (11)
| Country | Link |
|---|---|
| CN (1) | CN1027225C (fr) |
| BE (1) | BE1002333A3 (fr) |
| CA (1) | CA1329764C (fr) |
| FR (1) | FR2623090B1 (fr) |
| IL (1) | IL88316A (fr) |
| IT (1) | IT1223132B (fr) |
| MY (1) | MY104345A (fr) |
| NZ (1) | NZ226812A (fr) |
| PT (1) | PT88978B (fr) |
| ZA (1) | ZA888391B (fr) |
| ZW (1) | ZW14688A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT8920486A0 (it) * | 1989-05-12 | 1989-05-12 | Isf Spa | Composizioni farmaceutiche. |
| DE69001991T2 (de) * | 1989-11-16 | 1993-09-23 | Phidea Spa | Fluessige arzneimittel zur nasalen anwendung, die ein polypeptid als wirksubstanz enthalten. |
| IT1238072B (it) * | 1990-01-19 | 1993-07-03 | Sclavo Spa | Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina |
| IT1248725B (it) * | 1990-06-12 | 1995-01-26 | Sclavo Spa | Composizione farmaceutica in polvere per somministrazione per via nasale contenente essenzialmente calcitonina ed un eccipiente idrosolubile |
| CN101721376B (zh) * | 2009-12-30 | 2011-06-01 | 上海交通大学 | 降钙素缓释微球组合物及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5927978A (ja) * | 1982-08-09 | 1984-02-14 | Terumo Corp | インドメタシン入り粘着テ−プ |
| JPS61267528A (ja) * | 1984-11-26 | 1986-11-27 | Yamanouchi Pharmaceut Co Ltd | 吸収促進剤を含有するカルシトニン経鼻剤 |
| CA1335076C (fr) * | 1987-04-01 | 1995-04-04 | Hanna R. Kowarski | Composition pharmaceutique et mode d'administration par voie intranasale |
-
1987
- 1987-11-13 IT IT22647/87A patent/IT1223132B/it active Protection Beyond IP Right Term
-
1988
- 1988-10-31 MY MYPI88001240A patent/MY104345A/en unknown
- 1988-11-02 NZ NZ226812A patent/NZ226812A/xx unknown
- 1988-11-02 CA CA000581928A patent/CA1329764C/fr not_active Expired - Fee Related
- 1988-11-04 ZW ZW146/88A patent/ZW14688A1/xx unknown
- 1988-11-07 IL IL88316A patent/IL88316A/xx not_active IP Right Cessation
- 1988-11-08 FR FR888814576A patent/FR2623090B1/fr not_active Expired - Fee Related
- 1988-11-09 ZA ZA888391A patent/ZA888391B/xx unknown
- 1988-11-10 PT PT88978A patent/PT88978B/pt not_active IP Right Cessation
- 1988-11-10 BE BE8801287A patent/BE1002333A3/fr not_active IP Right Cessation
- 1988-11-12 CN CN88107895A patent/CN1027225C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IT8722647A0 (it) | 1987-11-13 |
| CA1329764C (fr) | 1994-05-24 |
| ZA888391B (en) | 1989-08-30 |
| PT88978B (pt) | 1993-04-30 |
| BE1002333A3 (fr) | 1990-12-18 |
| FR2623090B1 (fr) | 1994-09-09 |
| ZW14688A1 (en) | 1989-08-02 |
| PT88978A (pt) | 1988-12-01 |
| IT1223132B (it) | 1990-09-12 |
| IL88316A (en) | 1993-04-04 |
| CN1027225C (zh) | 1995-01-04 |
| NZ226812A (en) | 1990-06-26 |
| CN1033568A (zh) | 1989-07-05 |
| FR2623090A1 (fr) | 1989-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY107056A (en) | Lactam free cyclic amino acids. | |
| PT80303B (pt) | Processo para a preparacao de composicoes para a higiene bucal | |
| CA1264740C (fr) | Agents therapeutiques tetrapyrrole | |
| PT80079A (en) | Process for the preparation of antiviral pharmaceutical preparations containing 2-diethylamino-2,2',6'-acetoxyxylidide (lidocaine) | |
| CA2116066A1 (fr) | Composition stabilisee de troponine pour dosages immunologiques et procede de stabilisation de la troponine pour dosages immunologiques | |
| ES8605956A1 (es) | Procedimiento para preparar una composicion antiacido | |
| HUT59833A (en) | Process for producing pharmaceutical compositions containing calcitoninogene like peptides for treating erectional disfunctions | |
| JPS56140913A (en) | High foaming tooth paste | |
| MY104345A (en) | Pharmaceutical compositions | |
| PH15789A (en) | Composition for use in pulp production | |
| ES8503026A1 (es) | Procedimiento para preparar un aceite de menta piperita que tiene un contenido de mentofurano reducido. | |
| ES8700272A1 (es) | Procedimiento para la preparacion y purificacion de peptidos | |
| DE3760489D1 (en) | Aroma composition, the use thereof and the process for the preparation thereof | |
| JPS6468310A (en) | Trichogenous and hair-tonic agent | |
| GR3001420T3 (en) | Prazosin-pirbuterol combination for bronchodilation | |
| IT1251685B (it) | Composizioni farmaceutiche contenenti una calcitonina | |
| MY102425A (en) | Preservative for wood | |
| AU554432B2 (en) | High concentration amine oxide formulations | |
| DE3762854D1 (de) | Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen. | |
| EP0063328A3 (fr) | Compositions contenant la sécrétine et procédé pour prévenir l'adsorption de la sécrétine | |
| ES8500217A1 (es) | Un procedimiento para preparar peptidos sinteticos del tipo de las calcitoninas. | |
| PT76218B (en) | Process for the preparation of a fabric softening composition concerning lanoline and analogous materials | |
| Shahed et al. | Stimulation of adenylate cyclase activity by Na sub (2) PO sub (3) F and NaF in intact rat hepatocytes and plasma membrane fractions. | |
| Bik et al. | Aluminum Plant as a Source of Emission of Fluorine Compounds | |
| AU570724B2 (en) | Preparation of compounds containing carboxamide groups |